"The study is a milestone as it is the first to publish efficacy data regarding the use of antibiotic eluting CERAMENT in
The study results show that the use of CERAMENT G or CERAMENT V not only significantly reduces the risk of amputation and surgical interventions but also promotes effective healing and shorter hospital stays compared to the control group receiving conventional treatment. The number of hospital days was 12.6 compared to 25.1 for the control group.
Today, approximately 540 million people worldwide live with diabetes, a number expected to increase to 640 million by 2030. Annually, about 1.6 million amputations are performed due to diabetic foot ulcers.
CERAMENT G is market approved in
© Modular Finance, source